Pro-life organizations are raising concerns about the FDA's delay in reviewing the abortion drug mifepristone. Learn more now.
Hawley and other anti-abortion groups and legislators say the health organization is "slow-walking" a review of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback